Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT03829020 · COMPLETED
Trial details
- NCT number
- NCT03829020
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-17
- Primary completion
- 2022-09-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.